A comparative clinical study to evaluate the efficacy of yashtimadhu madhu avapeeda nasya with vacha pippali avapeeda nasya in suryavarta( frontal sinusitis)
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- The effect of treatment will be assessed based on detailed case proforma adopting methods of subjective parameters such as site, intensity and nature of pain. And also according to objective criteria like tenderness over sinus area and ESR. Pre and post interventional assessment will be done
研究概览
简要总结
This is randomized control clinical study to evaluate the efficacy of yashtimadhu madhu avapeeda nasya with vacha pippali avapeeda nasya in suryavarta for 7 days in 40 patients in OPD and IPD of PG studies in shalakya tantra of Alvas ayurveda medical college and hospital, Vidyagiri, Moodbidri, DK district, Karnataka.
Assessment will be done based on detailed case proforma adopting standard scoring methods of subjective and objective parameters.
Pre and post assessment will be done , clinical symptoms will be graded and scores will be given accordingly.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 16.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patient within the age group of 16 to 60 years who will give their written consent
- •pt who will agree to follow protocol of study 3.subjects with symptoms of: a)shirashoola dinavruddha b) lalataruk c)akshiruk d)shankaruk e)spandanavat vedana f)tenderness over sinus area.
排除标准
- •Subjects with complications of sinusitis.
- •Pregnant and lactating women.
- •Headaches with involvement of other intracranial pathology.
- •Subjects contraindicated for nasya.
- •Patients with other systemic illness.
结局指标
主要结局
The effect of treatment will be assessed based on detailed case proforma adopting methods of subjective parameters such as site, intensity and nature of pain. And also according to objective criteria like tenderness over sinus area and ESR. Pre and post interventional assessment will be done
时间窗: The effect of treatment will be assessed before treatment( day 0), after treatment( day 7) and on day 14, 21 and 52
次要结局
未报告次要终点